Down Regulated Expression Levels of miR-27b and miR-451a as a Potential Biomarker for Triple Negative Breast Cancer Patients Undergoing TAC Chemotherapy.
Ahmad Aizat Abdul AzizMd Salzihan Md SallehMaya Mazuwin YahyaAndee Dzulkarnaen ZakariaRavindran AnkathilPublished in: Asian Pacific journal of cancer prevention : APJCP (2022)
The results suggest the possible utilization of miR-27b and miR-451a expression levels as potential predictive risk markers for TNBC patients undergoing TAC chemotherapy.